Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective

Tong Cheng, Dong Liu, John H. Griffin, José A. Fernández, Francis Castellino, Elliot Rosen, Kenji Fukudome, Berislav V. Zlokovic

Research output: Contribution to journalArticle

479 Citations (Scopus)

Abstract

Activated protein C (APC) is a systemic anti-coagulant and anti-inflammatory factor1-3. It reduces organ damage in animal models of sepsis, ischemic injury and stroke1,4,5 and substantially reduces mortality in patients with severe sepsis6. It was not known whether APC acts as a direct cell survival factor or whether its neuroprotective effect5,7 is secondary to its anticoagulant and anti-inflammatory effects1-3. We report that APC directly prevents apoptosis in hypoxic human brain endothelium through transcriptionally dependent inhibition of tumor suppressor protein p53, normalization of the pro-apoptotic Bax/Bcl-2 ratio and reduction of caspase-3 signaling. These mechanisms are distinct from those involving upregulation of the genes encoding the anti-apoptotic Bcl-2 homolog A1 and inhibitor of apoptosis protein-1 (IAP-1) by APC in umbilical vein endothelial cells8,9. Cytoprotection of brain endothelium by APC in vitro required endothelial protein C receptor (EPCR) and protease-activated receptor-1 (PAR-1), as did its in vivo neuroprotective activity in a stroke model of mice with a severe deficiency of EPCR10. This is consistent with work showing the direct effects of APC on cultured cells via EPCR and PAR-1 (ref. 9). Moreover, the in vivo neuroprotective effects of low-dose mouse APC seemed to be independent of its anti-coagulant activity. Thus, APC protects the brain from ischemic injury by acting directly on brain cells.

Original languageEnglish (US)
Pages (from-to)338-342
Number of pages5
JournalNature Medicine
Volume9
Issue number3
DOIs
StatePublished - Mar 1 2003
Externally publishedYes

Fingerprint

Protein C
Endothelium
Brain
Apoptosis
PAR-1 Receptor
Coagulants
Anti-Inflammatory Agents
Cells
Inhibitor of Apoptosis Proteins
Tumor Suppressor Protein p53
Umbilical Veins
Gene encoding
Cytoprotection
Neuroprotective Agents
Caspase 3
Anticoagulants
Brain Injuries
Cultured Cells
Cell Survival
Sepsis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Cheng, T., Liu, D., Griffin, J. H., Fernández, J. A., Castellino, F., Rosen, E., ... Zlokovic, B. V. (2003). Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nature Medicine, 9(3), 338-342. https://doi.org/10.1038/nm826

Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. / Cheng, Tong; Liu, Dong; Griffin, John H.; Fernández, José A.; Castellino, Francis; Rosen, Elliot; Fukudome, Kenji; Zlokovic, Berislav V.

In: Nature Medicine, Vol. 9, No. 3, 01.03.2003, p. 338-342.

Research output: Contribution to journalArticle

Cheng, T, Liu, D, Griffin, JH, Fernández, JA, Castellino, F, Rosen, E, Fukudome, K & Zlokovic, BV 2003, 'Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective', Nature Medicine, vol. 9, no. 3, pp. 338-342. https://doi.org/10.1038/nm826
Cheng, Tong ; Liu, Dong ; Griffin, John H. ; Fernández, José A. ; Castellino, Francis ; Rosen, Elliot ; Fukudome, Kenji ; Zlokovic, Berislav V. / Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. In: Nature Medicine. 2003 ; Vol. 9, No. 3. pp. 338-342.
@article{37368f32b028418c96b1f3092022e62b,
title = "Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective",
abstract = "Activated protein C (APC) is a systemic anti-coagulant and anti-inflammatory factor1-3. It reduces organ damage in animal models of sepsis, ischemic injury and stroke1,4,5 and substantially reduces mortality in patients with severe sepsis6. It was not known whether APC acts as a direct cell survival factor or whether its neuroprotective effect5,7 is secondary to its anticoagulant and anti-inflammatory effects1-3. We report that APC directly prevents apoptosis in hypoxic human brain endothelium through transcriptionally dependent inhibition of tumor suppressor protein p53, normalization of the pro-apoptotic Bax/Bcl-2 ratio and reduction of caspase-3 signaling. These mechanisms are distinct from those involving upregulation of the genes encoding the anti-apoptotic Bcl-2 homolog A1 and inhibitor of apoptosis protein-1 (IAP-1) by APC in umbilical vein endothelial cells8,9. Cytoprotection of brain endothelium by APC in vitro required endothelial protein C receptor (EPCR) and protease-activated receptor-1 (PAR-1), as did its in vivo neuroprotective activity in a stroke model of mice with a severe deficiency of EPCR10. This is consistent with work showing the direct effects of APC on cultured cells via EPCR and PAR-1 (ref. 9). Moreover, the in vivo neuroprotective effects of low-dose mouse APC seemed to be independent of its anti-coagulant activity. Thus, APC protects the brain from ischemic injury by acting directly on brain cells.",
author = "Tong Cheng and Dong Liu and Griffin, {John H.} and Fern{\'a}ndez, {Jos{\'e} A.} and Francis Castellino and Elliot Rosen and Kenji Fukudome and Zlokovic, {Berislav V.}",
year = "2003",
month = "3",
day = "1",
doi = "10.1038/nm826",
language = "English (US)",
volume = "9",
pages = "338--342",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective

AU - Cheng, Tong

AU - Liu, Dong

AU - Griffin, John H.

AU - Fernández, José A.

AU - Castellino, Francis

AU - Rosen, Elliot

AU - Fukudome, Kenji

AU - Zlokovic, Berislav V.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Activated protein C (APC) is a systemic anti-coagulant and anti-inflammatory factor1-3. It reduces organ damage in animal models of sepsis, ischemic injury and stroke1,4,5 and substantially reduces mortality in patients with severe sepsis6. It was not known whether APC acts as a direct cell survival factor or whether its neuroprotective effect5,7 is secondary to its anticoagulant and anti-inflammatory effects1-3. We report that APC directly prevents apoptosis in hypoxic human brain endothelium through transcriptionally dependent inhibition of tumor suppressor protein p53, normalization of the pro-apoptotic Bax/Bcl-2 ratio and reduction of caspase-3 signaling. These mechanisms are distinct from those involving upregulation of the genes encoding the anti-apoptotic Bcl-2 homolog A1 and inhibitor of apoptosis protein-1 (IAP-1) by APC in umbilical vein endothelial cells8,9. Cytoprotection of brain endothelium by APC in vitro required endothelial protein C receptor (EPCR) and protease-activated receptor-1 (PAR-1), as did its in vivo neuroprotective activity in a stroke model of mice with a severe deficiency of EPCR10. This is consistent with work showing the direct effects of APC on cultured cells via EPCR and PAR-1 (ref. 9). Moreover, the in vivo neuroprotective effects of low-dose mouse APC seemed to be independent of its anti-coagulant activity. Thus, APC protects the brain from ischemic injury by acting directly on brain cells.

AB - Activated protein C (APC) is a systemic anti-coagulant and anti-inflammatory factor1-3. It reduces organ damage in animal models of sepsis, ischemic injury and stroke1,4,5 and substantially reduces mortality in patients with severe sepsis6. It was not known whether APC acts as a direct cell survival factor or whether its neuroprotective effect5,7 is secondary to its anticoagulant and anti-inflammatory effects1-3. We report that APC directly prevents apoptosis in hypoxic human brain endothelium through transcriptionally dependent inhibition of tumor suppressor protein p53, normalization of the pro-apoptotic Bax/Bcl-2 ratio and reduction of caspase-3 signaling. These mechanisms are distinct from those involving upregulation of the genes encoding the anti-apoptotic Bcl-2 homolog A1 and inhibitor of apoptosis protein-1 (IAP-1) by APC in umbilical vein endothelial cells8,9. Cytoprotection of brain endothelium by APC in vitro required endothelial protein C receptor (EPCR) and protease-activated receptor-1 (PAR-1), as did its in vivo neuroprotective activity in a stroke model of mice with a severe deficiency of EPCR10. This is consistent with work showing the direct effects of APC on cultured cells via EPCR and PAR-1 (ref. 9). Moreover, the in vivo neuroprotective effects of low-dose mouse APC seemed to be independent of its anti-coagulant activity. Thus, APC protects the brain from ischemic injury by acting directly on brain cells.

UR - http://www.scopus.com/inward/record.url?scp=0037352279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037352279&partnerID=8YFLogxK

U2 - 10.1038/nm826

DO - 10.1038/nm826

M3 - Article

C2 - 12563316

AN - SCOPUS:0037352279

VL - 9

SP - 338

EP - 342

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 3

ER -